Landmark Daubert Decision Develops New Standard for Admission of Expert Evidence

BVLaw
Court Case Digests
June 28, 1993

Access the Full Article

This article is available with a subscription to any of these products:
It is also available in this product:
Already a subscriber or product owner?  Login
This article is also available for purchase. (1,367 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
expert testimony
daubert, expert testimony, rule 702, reliability, Frye
Daubert v. Merrell Dow Pharmaceuticals, Inc.
1993 U.S. LEXIS 4408, 509 U.S. 579, 113 S. Ct. 2786, 125 L. Ed. 2d 469, 27 U.S.P.Q.2D (BNA) 1200, 61 U.S.L.W. 4805, 93 Cal. Daily Op. Service 4825, 93 Daily Journal DAR 8148, 23 ELR 20979, CCH Prod. Liab. Rep. P13,494, 7 Fla. L. Weekly Fed. S 632
US
Federal Court
Federal
Supreme Court
Blackmun

Summary

Landmark decision by the U.S. Supreme Court, which ended by promulgating a new “gatekeeping” function for federal judges and developing an evidentiary standard now known by a single name: Daubert.

See Also

Daubert v. Merrell Dow Pharmaceuticals, Inc.

Full Text of Court Cases
June 28, 1993

Landmark decision by the U.S. Supreme Court, which ended by promulgating a new “gatekeeping” function for federal judges and developing an evidentiary standard now known by a single name: Daubert.

This article also appears in:
The Comprehensive Guide to Economic Damages, Seventh Edition